Results 91 to 100 of about 738,105 (258)
Supplementation with mannan oligosaccharides (MOS) enhances growth, disease resistance, antioxidant capacity, and gut microbiota diversity while suppressing inflammation, apoptosis, and strengthening intestinal barrier integrity in zebrafish challenged with LPS or DSS.
Zhiyuan Lu +4 more
wiley +1 more source
Engineered bacteria serve as smart, living therapeutics that target tumors, deliver drugs, and remodel immunosuppressive microenvironments. This review highlights their potential to potentiate immunotherapy, radiotherapy, and chemotherapy, offering a promising paradigm for precise and synergistic cancer treatment. Abstract The dynamic interplay between
Haonan Shen +9 more
wiley +1 more source
Fecal microbiota transplantation (FMT) is an effective tool for treating Clostridium difficile infection in the setting of dysbiosis of the intestinal microbiome. FMT for other forms of human disorders linked to dysbiosis have been less effective.
Derek M. Lin +6 more
doaj +1 more source
Flow chart of studies of fecal microbiota transplantation in ulcerative colitis.
Flow chart of studies of fecal microbiota transplantation in ulcerative colitis.
Yanqiang Shi (2832755) +5 more
core +1 more source
Fecal microbiota transplantation (FMT) has been suggested as an alternative therapeutic option to decolonize carbapenem-resistant Enterobacteriaceae (CRE).
Ki Tae Suk +6 more
core +1 more source
Dietary Artificial Sweeteners: From Chemical Transformation in Food to Gut Microbial Processing
This review article unites classical and recent findings on the stability of artificial sweeteners in food. The focus is on ten sweeteners approved in the European Union: their chemical stability during processing and storage, individual degradation products, and their interactions with the intestinal microbiota.
Jürgen Lassak, Michael Hellwig
wiley +1 more source
Scores of the patients’ questionnaires before and after fecal microbiota transplantation.
Scores of the patients’ questionnaires before and after fecal microbiota transplantation.
Jan Gunnar Hatlebakk (5963021) +7 more
core +1 more source
Abstract The immune system has long been recognized as a key driver in the progression of heart failure (HF). However, clinical trials targeting immune effectors have consistently failed to improve patient outcome across different HF aetiologies. The activation of the immune system in HF is complex, involving a broad network of pro‐inflammatory and ...
Johann Roessler +4 more
wiley +1 more source
Abstract Objective The ketogenic diet (KD) is a high‐fat, low‐carbohydrate intervention widely used to treat drug‐resistant epilepsy, thought to reduce seizures through a combination of metabolic, neuronal, and microbiota‐dependent mechanisms. Additionally, recent studies suggest that the anticonvulsant effects of KD require the gut microbiota, with ...
Casey H. Meili +4 more
wiley +1 more source
Fecal Microbiota Transplantation in a Domestic Ferret Suffering from Chronic Diarrhea and Maldigestion–Fecal Microbiota and Clinical Outcome: A Case Report [PDF]
Sean J Ravel, Victoria M Hollifield Best Friends’ Veterinary Hospital, Gaithersburg, MD, USACorrespondence: Sean J Ravel, Email sean.ravel01@gmail.comAbstract: This case report describes the effects of fecal microbiota transplantation (FMT) administered ...
Ravel SJ, Hollifield VM
core

